Expires: January 14, 2023
This “Specialty Testing” webinar will discuss how hearing loss is diagnosed and how patient outcomes can be improved by genetic testing. Strategies for testing and confirming results will also be reviewed.
Video length: 49 minutes
Lisa Schimmenti, M.D., FACMG, FAAP
Consultant, Departments of Clinical Genomics, Otorhinolaryngology, and Biochemistry and Molecular Biology
Co-Director, Medical Scientist Training Program (M.D./Ph.D.)
Mayo Clinic, Rochester, Minnesota
Upon completion of this activity, participants should be able to:
- Identify how hearing loss is diagnosed.
- Recognize how to distinguish non-syndromic hearing loss from syndromic hearing loss.
- Develop strategies for testing and confirming results.
- Name three ways patient outcomes can be improved by genetic testing.
This webinar is designed for any provider who sees patients with neurologic diseases (e.g., neurologists, psychiatrists, and primary care physicians, including internists and family care practitioners) as well as pathologists, laboratory directors, and laboratory send-out coordinators.
Level of instruction for this program is advanced.
To obtain credit:
- Watch the video.
- Complete the posttest and evaluation that launches immediately following the video.
- Generate and print your certificate(s).
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.
State of California
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for the State of California. This program has been approved for 1.0 contact hour.
State of Florida
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General credit. This program has been approved for 1.0 contact hour.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Learn more about our testing
Contact us: firstname.lastname@example.org